Zim LaboratoriesNSE:ZIMLAB -2.32%76 Days Inventory is 181.58 as of Mar. 2026, which is 36% above its 10-year median of 133.72. GuruFocus rates NSE:ZIMLAB with a GF Score™ of 76/100 and a GF Value™ of ₹102.87 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 919 Drug Manufacturers companies, Zim Laboratories ranks worse than 65.18% on this metric.
The historical rank and industry rank for Zim Laboratories's Days Inventory or its related term are showing as below:
NSE:ZIMLAB'
s Days Inventory Range Over the Past 10 Years
Min: 111.01 Med: 133.72 Max: 202.93
Current: 202.93
During the past 12 years, Zim Laboratories's highest Days Inventory was 202.93. The lowest was 111.01. And the median was 133.72.
NSE:ZIMLAB's Days Inventory is ranked worse than 65.18% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.83
vs NSE:ZIMLAB: 202.93
Zim Laboratories's Days Inventory
increased
from Mar. 2025 (163.51) to Mar. 2026 (181.58).
It might indicate that Zim Laboratories's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zim Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.50.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zim Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.89.
Zim Laboratories (NSE:ZIMLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zim Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zim Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zim Laboratories Days Inventory Related Terms
Zim Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Zim Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zim Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zim Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zim Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zim Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zim Laboratories (NSE:ZIMLAB) has a Days Inventory of 181.58 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zim Laboratories and its competitors. This is 36% above median its historical median of 133.72. Over the past decade, Zim Laboratories' Days Inventory has ranged from 111.01 to 202.93. According to the industry distribution chart, Zim Laboratories ranks #599 out of 919 companies in the Drug Manufacturers industry, placing it in the top 65.2%.
Is Zim Laboratories' Days Inventory too high?
Zim Laboratories' current Days Inventory of 181.58 is 36% above median its 10-year median of 133.72. Over the past 10 years, this metric has ranged from a low of 111.01 to a high of 202.93. The Drug Manufacturers industry median Days Inventory is 162.83. Zim Laboratories' value of 181.58 is 11.5% above this industry median. Based on the distribution chart, Zim Laboratories ranks #599 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zim Laboratories has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zim Laboratories' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zim Laboratories ranks #599 out of 919 companies for Days Inventory. This places Zim Laboratories in the lower half of its industry. The industry median Days Inventory is 162.83. Zim Laboratories' value of 181.58 is 11.5% above this benchmark. Historically, Zim Laboratories' own Days Inventory has ranged from 111.01 to 202.93 over the past decade. While the company's 10-year median is 133.72 vs. the industry median of 162.83, Zim Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zim Laboratories's current Days Inventory of 181.58 is 11.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zim Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zim Laboratories's current Days Inventory is 181.58, which is 36% above median its own 10-year median of 133.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zim Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Zim Laboratories (NSE:ZIMLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹102.87, compared to a current price of ₹124.90 — trading 21.4% above its estimated fair value. The current Days Inventory is 181.58, which is 36% above median its 10-year median of 133.72 and 11.5% above the Drug Manufacturers industry median of 162.83. Zim Laboratories' overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zim Laboratories (NSE:ZIMLAB), the current Days Inventory is 181.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zim Laboratories (NSE:ZIMLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Zim Laboratories stock appears to be overvalued.
The current stock price of ₹124.90 is trading 21.4% above its estimated GF Value™ of ₹102.87.
GuruFocus considers Zim Laboratories to be Modestly Overvalued.
Key valuation signals for NSE:ZIMLAB:
Days Inventory: 181.58 (36% above median its 10-year median of 133.72)
GF Value™: ₹102.87 vs. price of ₹124.90 (21.4% above fair value)
Industry Position: 11.5% above the Drug Manufacturers median (#599 of 919)
No single metric tells the full story. See the NSE:ZIMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zim Laboratories Ltd is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. It is engaged in manufacturing &wholesale of pharmaceutical products, market research and research & development activities. The Group is mainly engaged in the business of pharmaceuticals. It has presence in India and Outside India. The company generates majority of revenue from India. Its products are Oral Thin Films, Pre-formulations Intermediates, Finished Formulations.
76GF Score
Get the complete analysis for NSE:ZIMLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ZIMLAB has been successfully added to your 
